Response to activated protein C during normal menstrual cycle and ovarian stimulation

Human Reproduction

Volumn 15, Issue 4, 2000, Pages 795-797

  Wramsby, M L ^a,c   Bokarewa, M I ^a   Biomback M ^b   Bremme, A K ^a  

^a Box 140 ^*  (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

APC resistance; Menstrual cycle; Ovarian stimulation

Indexed keywords

ACTIVATED PROTEIN C; BUSERELIN; CHORIONIC GONADOTROPIN; DRUG ANALOG; ESTROGEN; FOLLITROPIN; GONADORELIN; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOWN REGULATION; DRUG RESPONSE; FEMALE; FERTILIZATION IN VITRO; HUMAN; MENSTRUAL CYCLE; OVARY HYPERSTIMULATION; RISK ASSESSMENT;

FALLOPIA;

EID: 0034025699     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.4.795     Document Type: Article

References (13)

1. Aune, B., Høie, K.E. and Øian, P. (1991) Does ovarian Stimulation for m vitro fertilization induce a hypercoagulate state? Hum. Reprod., 6, 925-927.
2. Bertina, R.M., Koeleman, B.P.C., Koster, F. et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64-67.
3. Blombäck, M., Eneroth, P., Landgren, B.-M. etal. (1992) On the intraindividual and gender variability of haemostatic components. Tlimmb. Haemost., 67, 70-75.
4. Bokarewa, M., Wramsby, M., Bremme, K. et al. (1997) Variability of the response to activated protein C during normal pregnancy. Blood Coag. Fibrin., 8, 239-244.
5. van der Bom, J.G., Bots, M.L., Haverkare, P. et al. (1996) Reduced response to activated protein C is associated with increased risk for cerebrovascular disease. Ann. Int. Med., 72, 255-260.
6. Bremme, K., Wramsby, H., Andersson, O. et al. (1994) Do lowered factor VII levels at extremely high endogenous estradiol levels protect against thrombin formation? Blood Coag. Fibrin., 5, 205-210.
7. Cumming, A., Tait, R.C., Fildes, S. et al. (1996) Diagnosis of APC resistance during pregnancy. Br. J. HaematoL, 92, 1026-1027.
8. Dahlbäck, B., Carlsson, M. and Svensson, P.J. (1993) Familial thrombophilia due to a previously unrecognised mechanism characterised by poor response to activated protein C. Prediction of a cofactor to activated protein C. Proc. NatlAcad. Sei. USA, 90, 1004-1008.
9. Gandrille, S., Alhenc-Gelas, M. and Aiach, M. (1995) A rapid screening method for the factor V Arg506-Gln mutation. Blood Coag. Fibrin., 6, 245-248.
10. Henkens, C.M.A., Bom, A.J., Seinen, J. el ai. (1995a) Sensitivity to activated protein C; influence of oral contraceptives and sex. Thromb. Haemost., 73, 402-104.
11. Henkens C.M.A., Bom, A.J. and van der Meer, J. (1995b) Lowered APC sensitivity ratio related to increased VIH-clotting activity. Thromb. Haemost., 74, 1198-1199.
12. Oliviero, O., Friso, S., Manzato, F. et al. (1995) Resistance to activated protein C in healthy women taking oral contraceptives. Br. J. HaematoL, 91, 465-470.
13. Sakata, T., Kario, K., Katayama, Y. et al. (1996) Clinical significance of acquired protein C resistance as a potential marker for hypercoagulable state. Thromb. Res., 82, 235-244.